C12Y 301/04039
Alkylglycerophosphoethanolamine phosphodiesterase
Official title: Alkylglycerophosphoethanolamine phosphodiesterase (3.1.4.39)
C12Y301/04039 (Alkylglycerophosphoethanolamine phosphodiesterase) appears on 2 US grants and 4 published applications in this corpus.
Search patents in C12Y- Granted patents
- 2
- Published applications
- 4
- Assignees
- 4
- Inventors
- 6
- Latest grant
- 23 Feb 2016
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 2011 | 0 | 1 |
| 2012 | 0 | 0 |
| 2013 | 0 | 0 |
| 2014 | 1 | 1 |
| 2015 | 0 | 0 |
| 2016 | 1 | 0 |
| 2017 | 0 | 1 |
| 2018 | 0 | 0 |
| 2019 | 0 | 0 |
| 2020 | 0 | 0 |
| 2021 | 0 | 0 |
| 2022 | 0 | 0 |
| 2023 | 0 | 0 |
| 2024 | 0 | 0 |
| 2025 | 0 | 1 |
By publication year.
Recent patents
- Activity measurement method of lysophospholipase d, sensitivity improver for activity measurement of lysophospholipase d, composition, and kit23 Jan 2025US 2025/0027135 A1FUJIFILM Corporation
- Aptamer inhibiting biological activity of autotaxin by binding with autotaxin, and use thereof18 May 2017US 2017/0137818 A1Ribomic Inc.
- Therapeutic or prophylactic agent for generalized pain syndrome23 Oct 2014US 2014/0315980 A1MSS, Inc.
- Therapeutic or prophylactic agent for generalized pain syndrome28 Jul 2011US 2011/0182917 A1MSS, Inc.
Most cited
By later US patents
No patent in this class has been cited by a later US patent yet.